| RS2125580580 |
SLC25A38
|
Health Risk |
Conflicting classifications of pathogenicity |
Sideroblastic anemia 2, Sideroblastic anemia 2 |
| RS2125580600 |
SLC25A38
|
Health Risk |
Pathogenic |
Sideroblastic anemia 2, Sideroblastic anemia 2 |
| RS2125580802 |
SETD5
|
Health Risk |
Pathogenic |
— |
| RS2125582750 |
SLC25A38
|
Health Risk |
Pathogenic |
Sideroblastic anemia 2, Sideroblastic anemia 2 |
| RS2125582823 |
SLC25A38
|
Health Risk |
Pathogenic |
Sideroblastic anemia 2, Sideroblastic anemia 2 |
| RS2125582841 |
SLC25A38
|
Health Risk |
Pathogenic |
Sideroblastic anemia 2, Sideroblastic anemia 2 |
| RS2125582986 |
SLC25A38
|
Health Risk |
Pathogenic |
Sideroblastic anemia 2, Sideroblastic anemia 2 |
| RS2125584589 |
SLC25A38
|
Health Risk |
Pathogenic |
Sideroblastic anemia 2, Sideroblastic anemia 2 |
| RS2125584640 |
SLC25A38
|
Health Risk |
Pathogenic |
Sideroblastic anemia 2, Sideroblastic anemia 2 |
| RS2125591475 |
GLB1
|
Health Risk |
Pathogenic |
Infantile GM1 gangliosidosis, Infantile GM1 gangliosidosis |
| RS2125591484 |
GLB1
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-IV-B |
| RS2125596197 |
CRTAP
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 7, Osteogenesis imperfecta type 7 |
| RS2125597503 |
KIF1A
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 30, Neuropathy |
| RS2125598333 |
KIF1A
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 30, Neuropathy |
| RS2125602711 |
CRTAP
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type 7, Osteogenesis imperfecta type 7 |
| RS2125603874 |
CRTAP
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 7, Osteogenesis imperfecta type 7 |
| RS2125616991 |
CTNNB1
|
Health Risk |
Pathogenic |
— |
| RS2125617589 |
CTNNB1
|
Health Risk |
Pathogenic |
Severe intellectual disability-progressive spastic diplegia syndrome, Severe intellectual disability-progressive spastic diplegia syndrome |
| RS2125617859 |
CTNNB1
|
Health Risk |
Pathogenic |
Severe intellectual disability-progressive spastic diplegia syndrome, Severe intellectual disability-progressive spastic diplegia syndrome |
| RS2125617982 |
CTNNB1
|
Health Risk |
Pathogenic |
— |
| RS2125619523 |
CTNNB1
|
Health Risk |
Likely pathogenic |
Severe intellectual disability-progressive spastic diplegia syndrome, Severe intellectual disability-progressive spastic diplegia syndrome |
| RS2125619545 |
CTNNB1
|
Health Risk |
Pathogenic |
Severe intellectual disability-progressive spastic diplegia syndrome, Severe intellectual disability-progressive spastic diplegia syndrome |
| RS2125619553 |
CTNNB1
|
Health Risk |
Pathogenic |
Nonpapillary renal cell carcinoma, Nonpapillary renal cell carcinoma |
| RS2125620428 |
CTNNB1
|
Health Risk |
Pathogenic |
— |
| RS2125620433 |
CTNNB1
|
Health Risk |
Pathogenic |
— |
| RS2125620755 |
CTNNB1
|
Health Risk |
Pathogenic |
— |
| RS2125621297 |
CTNNB1
|
Health Risk |
Pathogenic |
— |
| RS2125622579 |
CTNNB1
|
Health Risk |
Pathogenic |
Severe intellectual disability-progressive spastic diplegia syndrome, Severe intellectual disability-progressive spastic diplegia syndrome |
| RS2125623075 |
CTNNB1
|
Health Risk |
Pathogenic |
Severe intellectual disability-progressive spastic diplegia syndrome, Severe intellectual disability-progressive spastic diplegia syndrome |
| RS2125623360 |
CTNNB1
|
Health Risk |
Pathogenic |
Severe intellectual disability-progressive spastic diplegia syndrome, Severe intellectual disability-progressive spastic diplegia syndrome |
| RS2125623412 |
CTNNB1
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2125623951 |
CTNNB1
|
Health Risk |
Pathogenic |
Colorectal cancer, Severe intellectual disability-progressive spastic diplegia syndrome |
| RS2125624259 |
CTNNB1
|
Health Risk |
Pathogenic |
— |
| RS2125624969 |
CTNNB1
|
Health Risk |
Likely pathogenic |
— |
| RS2125628072 |
CTNNB1
|
Health Risk |
Pathogenic |
— |
| RS2125628162 |
CTNNB1
|
Health Risk |
Likely pathogenic |
Severe intellectual disability-progressive spastic diplegia syndrome, Severe intellectual disability-progressive spastic diplegia syndrome |
| RS2125628404 |
CTNNB1
|
Health Risk |
Likely pathogenic |
— |
| RS2125629897 |
GMPPA
|
Health Risk |
Likely pathogenic |
Alacrima, achalasia |
| RS2125632199 |
SETD5
|
Health Risk |
Likely pathogenic |
— |
| RS2125637461 |
CTNNB1
|
Health Risk |
Pathogenic |
Severe intellectual disability-progressive spastic diplegia syndrome, Severe intellectual disability-progressive spastic diplegia syndrome |
| RS2125637783 |
CTNNB1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2125637830 |
CTNNB1
|
Health Risk |
Pathogenic |
— |
| RS2125638080 |
CTNNB1
|
Health Risk |
Likely pathogenic |
Severe intellectual disability-progressive spastic diplegia syndrome, Severe intellectual disability-progressive spastic diplegia syndrome |
| RS2125638106 |
CTNNB1
|
Health Risk |
Pathogenic |
Severe intellectual disability-progressive spastic diplegia syndrome, Severe intellectual disability-progressive spastic diplegia syndrome |
| RS2125638578 |
CTNNB1
|
Health Risk |
Likely pathogenic |
— |
| RS2125638582 |
CTNNB1
|
Health Risk |
Pathogenic |
— |
| RS2125639190 |
CTNNB1
|
Health Risk |
Pathogenic |
— |
| RS2125639278 |
CTNNB1
|
Health Risk |
Pathogenic |
— |
| RS2125639654 |
GMPPA
|
Health Risk |
Pathogenic |
Alacrima, achalasia |
| RS2125639718 |
CTNNB1
|
Health Risk |
Pathogenic |
Severe intellectual disability-progressive spastic diplegia syndrome, Severe intellectual disability-progressive spastic diplegia syndrome |
| RS2125640126 |
CTNNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
CTNNB1-related syndromic intellectual disability, CTNNB1-related syndromic intellectual disability |
| RS2125640624 |
CTNNB1
|
Health Risk |
Pathogenic |
— |
| RS2125640691 |
CTNNB1
|
Health Risk |
Pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2125640705 |
CTNNB1
|
Health Risk |
Pathogenic |
— |
| RS2125640866 |
CTNNB1
|
Health Risk |
Pathogenic |
— |
| RS2125641801 |
CTNNB1
|
Health Risk |
Pathogenic |
— |
| RS2125644619 |
CTNNB1
|
Health Risk |
Pathogenic |
— |
| RS2125644627 |
CTNNB1
|
Health Risk |
Pathogenic |
Severe intellectual disability-progressive spastic diplegia syndrome, Severe intellectual disability-progressive spastic diplegia syndrome |
| RS2125644658 |
CTNNB1
|
Health Risk |
Likely pathogenic |
— |
| RS2125645038 |
CTNNB1
|
Health Risk |
Pathogenic |
— |
| RS2125645060 |
CTNNB1
|
Health Risk |
Likely pathogenic |
Abnormality of the nervous system, Abnormality of the nervous system |
| RS2125645129 |
CTNNB1
|
Health Risk |
Likely pathogenic |
Severe intellectual disability-progressive spastic diplegia syndrome, Severe intellectual disability-progressive spastic diplegia syndrome |
| RS2125646219 |
CTNNB1
|
Health Risk |
Pathogenic |
— |
| RS2125646355 |
CTNNB1
|
Health Risk |
Likely pathogenic |
CTNNB1-related disorder, CTNNB1-related disorder |
| RS2125647138 |
CTNNB1
|
Health Risk |
Pathogenic |
Severe intellectual disability-progressive spastic diplegia syndrome, Severe intellectual disability-progressive spastic diplegia syndrome |
| RS2125650298 |
ARPC4
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Developmental delay |
| RS2125650519 |
CTNNB1
|
Health Risk |
Likely pathogenic |
— |
| RS2125652997 |
CTNNB1
|
Health Risk |
Pathogenic |
— |
| RS2125653005 |
CTNNB1
|
Health Risk |
Pathogenic |
— |
| RS2125653590 |
CTNNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2125672068 |
LARS2
|
Health Risk |
Pathogenic |
— |
| RS2125680264 |
LZTFL1
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 17, Bardet-Biedl syndrome 17 |
| RS2125682287 |
PIKFYVE
|
Health Risk |
Pathogenic |
— |
| RS2125682979 |
PIKFYVE
|
Health Risk |
Pathogenic |
Fleck corneal dystrophy, Fleck corneal dystrophy |
| RS2125693080 |
MLH1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2125693198 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS2125693258 |
MLH1
|
Health Risk |
Pathogenic |
— |
| RS2125693589 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS2125693612 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Colorectal cancer |
| RS2125693787 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Colorectal cancer |
| RS2125694037 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Colorectal cancer |
| RS2125694105 |
MLH1
|
Health Risk |
Pathogenic |
Lynch syndrome 1, Lynch syndrome 1 |
| RS2125694695 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS2125694907 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2125699699 |
POMGNT2
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a |
| RS2125700249 |
POMGNT2
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a |
| RS2125700641 |
POMGNT2
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a |
| RS2125700808 |
POMGNT2
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a |
| RS2125710774 |
MLH1
|
Health Risk |
Pathogenic/Likely pathogenic |
Endometrial carcinoma, Hereditary cancer-predisposing syndrome |
| RS2125711087 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS2125711616 |
MLH1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS2125711634 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS2125735291 |
MLH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS2125735738 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Colorectal cancer |
| RS2125736167 |
MLH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS2125739189 |
AFG2A
|
Health Risk |
Likely pathogenic |
Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome, Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome |
| RS2125750668 |
LARS2
|
Health Risk |
Pathogenic |
Perrault syndrome 4, Perrault syndrome 4 |
| RS2125756455 |
MLH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS2125756776 |
MLH1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2125757477 |
MLH1
|
Health Risk |
Pathogenic |
Carcinoma of colon, Carcinoma of colon |